Victory Square Technologies Inc
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Shafin Diamond Tejani
- Full Time Employees
- 2
- Sector
- Technology services
- Industry
- Information technology services
- Address
- 800 – 1500 West Georgia Vancouver BC Canada V6G 2Z6
- IPO Date
- May 4, 2016
- Website
- victorysquare.com
- Similar Companies
- Business
- Victory Square Technologies Inc. (CSE: VST, OTCQX: VSQTF) is a Vancouver-based venture builder and investor that builds, acquires and invests in early-stage startups focused on disruptive technologies; its portfolio of more than 25 companies spans sectors including artificial intelligence, blockchain, Web3, digital health, gaming, the creator economy, metaverse, virtual/augmented reality, climate tech, fintech, insurance and esports. The company provides senior leadership, operational resources and strategic support to accelerate portfolio growth and monetization, offering investors liquid exposure to high-potential tech ventures without traditional venture fund restrictions; key portfolio assets include Hydreight for at-home health services, VSDHOne for telehealth platforms, XR Immersive Tech for VR/AR solutions, Insu Therapeutics advancing oral insulin and continuous glucose monitoring technologies, and Pawsible Ventures developing pet wellness funds. Founded in 2015 and headquartered at 800-1500 West Georgia Street in Vancouver, Canada, with an additional office in Lewes, Delaware, Victory Square operates globally with a strong emphasis on ESG principles, supporting underrepresented entrepreneurs and community initiatives in youth, mental health and education. Recent developments include the October 2024 completion of a $1.7 million strategic transaction divesting BlockX Capital to Edge Total Intelligence Inc., receiving 4.25 million shares valued at approximately $3.95 million and forming EdgeAI Technologies Inc. to expand AI capabilities; Q3 2024 net income of $10.7 million; 33% year-over-year revenue growth to $13.9 million in H1 2025 driven by Hydreight's profitable quarters; and advancements such as Hydreight's nationwide expansion of at-home blood testing and VSDHOne's new asynchronous telehealth offerings in skincare, hair loss and sexual health.
Company News
Hydreight Highlights U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Technology
Victory Square Announces U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Platform
Victory Square Technologies Ranks No. 2 Among Publicly Traded Companies on The Globe and Mail's 2026 Canada's Top Growing Companies List
Victory Square Technologies Reports First-Half 2026 Revenue of $53.0 Million and Net Income of $6.5 Million
Hydreight Reports Record Q2 2026 Revenue of $28.0 Million, Net Income of $2.5 Million and Adjusted EBITDA of $3.2 Million
Hydreight Reports Record Q2 2026 Revenue of $28.0 Million, Net Income of $2.5 Million and Adjusted EBITDA of $3.2 Million
Hydreight Technologies Announces Timing of Q2 2026 Financial Results and Investor Webcast Featuring Live Analyst Q&A
Hydreight to Participate in Canaccord Genuity's 46th Annual Growth Conference in Boston
Victory Square Provides Update on Hydreight and Healthcare Investments Following FDA Advisory Committee Recommendations on Peptide-Related Bulk Drug Substances
Hydreight Provides Business Update on its Peptide Healthcare Platform Following Recent FDA Advisory Committee Recommendations
Victory Square Reports Q1 2026 Financial Results and Provides Portfolio Update
Victory Square Reports Q1 2026 Financial Results and Provides Portfolio Update
Hydreight Delivers Record First Quarter 2026 Revenue of $24.9 Million with 449% Revenue Growth, $3.3 Million in Adjusted EBITDA² and $32.0 Million in Working Capital
Hydreight Delivers Record First Quarter 2026 Revenue of $24.9 Million with 449% Revenue Growth, $3.3 Million in Adjusted EBITDA² and $32.0 Million in Working Capital
Hydreight Technologies Announces Timing of Q1 2026 Financial Results and Investor Webcast
Victory Square Technologies Reports Fiscal 2025 Results Highlighting Platform Scaling, Healthcare Infrastructure Growth and Portfolio Momentum
Hydreight Reports Record Fiscal 2025 Results as VSDHOne Drives Rapid Growth and Platform Scale
Comparing U-BX Technology (NASDAQ:UBXG) and Victory Square Technologies (OTCMKTS:VSQTF)
Hydreight Announces Normal Course Issuer Bid
Victory Square Provides Corporate Update on Healthcare Infrastructure Strategy and Portfolio Developments